---
title: "VK2735 in Chronic weight management: Natural history, survival, and mortality"
description: "Formulary evidence on VK2735 in Chronic weight management: Natural history, survival, and mortality. Topics: Natural history: a chronic, relapsing course requiring lifelong care; Natural history: regain of lost weight; Natural history: defense of body weight after weight loss; Natural history: progression from preclinical to clinical obesity and end-organ damage; 4 further topics. 8 evidence topics quoted from 8 sources."
canonical: "https://www.evicenter.com/drugs/vk2735--chronic-weight-management/product-information-and-disease-description/natural-history-survival-and-mortality"
published: "2026-11-15T21:45:47-05:00"
modified: "2026-11-15T21:45:47-05:00"
---

# VK2735 in Chronic weight management: Natural history, survival, and mortality

<a id="heading-2.2.1.3"></a>

## 2.2.1.3 Natural History, Survival, and Mortality

<a id="topic-2.2.1.3-1"></a>

### Natural history: a chronic, relapsing course requiring lifelong care

> “The guidelines recognize obesity as a chronic, relapsing disease requiring lifelong care and emphasize early diagnosis and integrated, person-centered approaches combining behavioral, medical, surgical, and other interventions alongside prevention and management of comorbidities.”

Source: [Celletti et al. (2026)](https://pubmed.ncbi.nlm.nih.gov/41324410/)

<a id="topic-2.2.1.3-2"></a>

### Natural history: regain of lost weight

> “A lack of effective options for long-term weight reduction magnifies the enormity of this problem; individuals who successfully complete behavioral and dietary weight-loss programs eventually regain most of the lost weight.”
> “The latter process explains why weight lost through changes of diet and/or lifestyle tends to be regained over time, a major obstacle to effective obesity treatment.”

Source: [Schwartz et al. (2017)](https://pmc.ncbi.nlm.nih.gov/articles/PMC5546881/)

<a id="topic-2.2.1.3-3"></a>

### Natural history: defense of body weight after weight loss

> “The body responds to weight loss induced by hypocaloric diets through a robust defensive mechanism, which increases hunger and the desire to eat while decreasing energy expenditure.”
> “The equilibrium body weight is fiercely defended by the brain, regardless of whether this set point represents a so-called healthy weight or an excessive degree of body fat in people with overweight or obesity.”

Source: [Rubino et al. (2025)](https://pmc.ncbi.nlm.nih.gov/articles/PMC11870235/)

<a id="topic-2.2.1.3-4"></a>

### Natural history: progression from preclinical to clinical obesity and end-organ damage

> “Clinical obesity can lead to severe end-organ damage, causing life-altering and potentially life-threatening complications (eg, heart attack, stroke, and renal failure).”
> “Preclinical obesity is defined as excess adiposity with preserved organ and tissue function, accompanied by an increased risk of progression to clinical obesity or other non-communicable diseases.”
> “The development of organ dysfunction and obesity complications, whether cardiometabolic or biomechanical, can arise at different levels of adiposity in different individuals.”

Source: [Rubino et al. (2025)](https://pmc.ncbi.nlm.nih.gov/articles/PMC11870235/)

<a id="topic-2.2.1.3-5"></a>

### All-cause mortality by body mass index category: individual-participant data meta-analysis

> “The HR for obesity grade 1 (BMI 30·0–<35·0 kg/m2) was 1·45, 95% CI 1·41–1·48; the HR for obesity grade 2 (35·0–<40·0 kg/m2) was 1·94, 1·87–2·01; and the HR for obesity grade 3 (40·0–<60·0 kg/m2) was 2·76, 2·60–2·92.”
> “For BMI over 25·0 kg/m2, mortality increased approximately log-linearly with BMI; the HR per 5 kg/m2 units higher BMI was 1·39 (1·34–1·43) in Europe, 1·29 (1·26–1·32) in North America, 1·39 (1·34–1·44) in east Asia, and 1·31 (1·27–1·35) in Australia and New Zealand.”

Source: [Global BMI Mortality Collaboration (2016)](https://pmc.ncbi.nlm.nih.gov/articles/PMC4995441/)

<a id="topic-2.2.1.3-6"></a>

### Life expectancy: population-based cohort in the United Kingdom

> “Compared with individuals of healthy weight (BMI 18·5–24·9 kg/m2), life expectancy from age 40 years was 4·2 years shorter in obese (BMI ≥30·0 kg/m2) men and 3·5 years shorter in obese women”
> “Most causes, including cancer, cardiovascular diseases, and respiratory diseases, had a J-shaped association with BMI, with lowest risk occurring in the range 21–25 kg/m2.”

Source: [Bhaskaran et al. (2018)](https://pmc.ncbi.nlm.nih.gov/articles/PMC6249991/)

<a id="topic-2.2.1.3-7"></a>

### Mortality by maximum body mass index over 24 years of weight history: Framingham Heart Study

> “Among 6197 participants (mean [SD] age at baseline, 62.79 [8.98] years; 55.5% female), 3478 (56.1%) died during the follow-up.”
> “A monotonic association was observed between maximum BMI and mortality, with increasing risks observed across obese I (BMI of 30 to <35; hazard ratio [HR], 1.27; 95% CI, 1.14-1.41) and obese II (BMI of 35 to <40; HR, 1.93; 95% CI, 1.68-2.20) categories.”

Source: [Xu et al. (2018)](https://pmc.ncbi.nlm.nih.gov/articles/PMC6324399/)

<a id="topic-2.2.1.3-8"></a>

### Global deaths attributable to high body mass index

> “High BMI accounted for 4.0 million (2.7- 5.3) deaths globally, nearly 40% of which occurred among non-obese.”
> “More than two-thirds of deaths related to high BMI were due to cardiovascular disease.”

Source: [GBD 2015 Obesity Collaborators (2017)](https://pmc.ncbi.nlm.nih.gov/articles/PMC5477817/)

> “In 2023, higher-than-optimal BMI caused an estimated 3.7 million deaths by increasing the number of deaths from diseases such as cardiovascular diseases, diabetes and cancers”

Source: [WHO (2026)](https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight)

## Related pages
- [VK2735: Chronic weight management](https://www.evicenter.com/drugs/vk2735--chronic-weight-management) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management.md)
- [VK2735 in Chronic weight management: Terms and abbreviations](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/terms-and-abbreviations) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/terms-and-abbreviations.md)
- [VK2735: Chronic weight management](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/executive-summary) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/executive-summary.md)
- [VK2735 in Chronic weight management: Product information and disease description](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/product-information-and-disease-description) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/product-information-and-disease-description.md)
- [VK2735 in Chronic weight management: Clinical evidence](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/clinical-evidence) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/clinical-evidence.md)
- [VK2735 in Chronic weight management: Economic information and modeling report](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/economics) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/economics.md)
- [VK2735 in Chronic weight management: References](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/references) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/references.md)
